TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Scandinavian ChemoTech AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
572
|
254
|
43 |
| Financial expenses |
103
|
126
|
170 |
| Earnings before taxes |
-1,194
|
-1,901
|
-2,044 |
| EBITDA |
-934
|
-1,582
|
-1,614 |
| Total assets |
1,165
|
1,340
|
1,950 |
| Current assets |
676
|
649
|
1,062 |
| Current liabilities |
644
|
346
|
693 |
| Equity capital |
521
|
994
|
1,257 |
| - share capital |
1,016
|
808
|
540 |
| Employees (average) |
6
|
6
|
6 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
44.7%
|
74.2%
|
64.5% |
| Turnover per employee |
95
|
42
|
7 |
| Profit as a percentage of turnover |
-208.7%
|
-748.4%
|
-4753.5% |
| Return on assets (ROA) |
-93.6%
|
-132.5%
|
-96.1% |
| Current ratio |
105.0%
|
187.6%
|
153.2% |
| Return on equity (ROE) |
-229.2%
|
-191.2%
|
-162.6% |
| Change turnover |
326
|
212
|
38 |
| Change turnover % |
133%
|
497%
|
865% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-14% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.